Should children and adolescents with systemic lupus erythematosus be given statin therapy to prevent early atherosclerosis?

2011 ◽  
Vol 64 (1) ◽  
pp. 33-36 ◽  
Author(s):  
Angelo Ravelli
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Children And Adolescents ◽  
Statin Therapy ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Early Atherosclerosis

AB0538 Association of Homocysteine and Inflammatory Markers with Early Atherosclerosis in Patients with Systemic Lupus Erythematosus

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 984.2-984
Author(s):  
N.A. Bashlakova ◽  
T.D. Tyabut ◽  
H.E. Buhlova ◽  
A.V. Kundzer ◽  
G.V. Sherstyuk ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Inflammatory Markers ◽  
Systemic Lupus ◽  
Early Atherosclerosis

Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients

Lupus ◽  
2009 ◽  
Vol 18 (3) ◽  
pp. 249-256 ◽  
Author(s):  
F Cacciapaglia ◽  
EM Zardi ◽  
G Coppolino ◽  
F Buzzulini ◽  
D Margiotta ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Intima Media Thickness ◽  
Systemic Lupus ◽  
Media Thickness ◽  
Early Atherosclerosis

scholarly journals CLINICAL AND LABORATORIAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS IN CHILDREN AND ADOLESCENTS

2019 ◽  
Author(s):  
ROGÉRIO DO PRADO ◽  
THAIS AKEMI YOSHIMOTO ◽  
ALINE RODRIGUES LORETO ◽  
BEATRIZ JERONYMO PARDI ◽  
ROSELI O S SARNI
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Children And Adolescents ◽  
Lupus Erythematosus ◽  
Systemic Lupus

Systemic lupus erythematosus—management

2016 ◽  
Author(s):  
Ida Dzifa Dey ◽  
David Isenberg
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Immunosuppressive Drugs ◽  
Systemic Lupus ◽  
General Management ◽  
Autoimmune Rheumatic Disease ◽  
The Future ◽  
Early Atherosclerosis

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease with varied presentation and a disease course characterized by remission and flares. Over the last 50 years the prognosis of SLE has improved considerably. The introductions of corticosteroids and later of cytotoxic drugs, dialysis, and renal transplantation were the major contributors to this improvement. Nevertheless, the treatment and general management of lupus continues to present a challenge. While lupus may, for some patients, represent a relatively mild set of problems, many others require large doses of immunosuppressive drugs, which carry long-term concerns about side effects. New immunotherapeutic drugs, with actions more closely targeted to the immune cells and molecules involved in the pathogenesis of SLE, are being introduced and the future looks promising. The role of early atherosclerosis and cardiovascular disease as a cause of death in patients with SLE is increasingly recognized and will present further challenges in the future.

scholarly journals Study of early atherosclerosis in juvenile-onset systemic lupus erythematosus patients

2017 ◽  
Vol 44 (1) ◽  
pp. 11
Author(s):  
EmtethalA Said Ahmed ◽  
SaharS Ganeb ◽  
AhmedY El-shambaky ◽  
OsamaT Galal ◽  
MaiY Tohamy
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Juvenile Onset ◽  
Onset Systemic Lupus Erythematosus ◽  
Early Atherosclerosis
Sign in / Sign up

Export Citation Format

Share Document